Project Grant R16GM154191

Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $288K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Kennesaw, GA 30144, USA
Similar Awards
This three-year Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences totals $1,512,792 to fund research at Louisiana State University examining the gene regulatory networks affected by purine catabolites in bacterial pathogens. The research aims to identify additional transcription factors in Burkholderia thailandensis responsive to urate and xanthine, which accumulate in host tissues during infection due to production of reactive oxygen species....
This Project Grant award of $868,776.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to characterize a novel post-transcriptional regulator in the opportunistic pathogen Pseudomonas aeruginosa. The key objectives are to: Identify the direct regulatory targets of the RNA-binding protein PhaF under standard lab conditions, infection-relevant conditions, and in clinical isolates to...
This $849,713 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to elucidate RNA-RNA interaction networks during interbacterial interactions involving the bacterium Pseudomonas aeruginosa. The research team at Boston Children's Hospital seeks to define the small RNA (sRNA) interaction network in P. aeruginosa and decode the regulatory roles played by sRNAs during its interactions with other bacteria. The project will...
This $287,252 Project Grant from the National Science Foundation's Division of Human Resource Development, under the STEM Education program (CFDA 47.076), will support research and training at Fayetteville State University from August 2022 to July 2025. The University will investigate regulatory pathways of the virulence factor pyocyanin in Pseudomonas aeruginosa, an opportunistic pathogen. Researchers will characterize environmental influences on pyocyanin regulation, determine the effects of...
This $151,040 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the regulatory role of the small regulatory RNA BECO on essential virulence factors in the pathogen Pseudomonas aeruginosa. The research aims to determine how BECO controls the expression of the Type III Secretion System and pyochelin biosynthesis genes, which are critical for P....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program, provides $430,760 to the University of Pittsburgh to conduct research on improving host defense against the deadly Gram-negative bacterium, Pseudomonas aeruginosa. The key objectives are to: 1) Determine the role of the CXCR4 chemokine receptor and galectin-3 protein in the protective function of lung...
The Scripps Research Institute was awarded a $779,915 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 5-year grant, effective May 5, 2025, will support research to investigate the chromatin remodeling functions of polyphosphate condensates in the opportunistic pathogen Pseudomonas aeruginosa. The project aims to define the relationship between polyphosphate, a stress-responsive...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $205,000 to The Trustees of Princeton University to conduct research examining the influence of chromosome copy number on Pseudomonas aeruginosa persisters to fluoroquinolone antibiotics. The research aims to fill knowledge gaps in understanding persistence to this antibiotic class in this opportunistic pathogen that...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA 93.859 Biomedical Research and Research Training program, provides $361,297 to the University of Georgia Research Foundation to characterize the regulation of cell envelope biosynthesis in the bacterial pathogen Pseudomonas aeruginosa. The project aims to: (I) dissect the molecular basis of lipopolysaccharide (LPS) and peptidoglycan (PG) coordination and the physiological consequences of...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $239,348 to The Trustees of Columbia University in the City of New York to investigate the impact of regulatory T cells (Tregs) on host susceptibility to Pseudomonas aeruginosa infection. The key objectives are to evaluate whether Tregs protect against P. aeruginosa pneumonia by altering the airway...

TRANSCRIPTION FACTOR DISCOVERY IN THE OPPORTUNISTIC PATHOGEN PSEUDOMONAS AERUGINOSA - PROJECT SUMMARY PSEUDOMONAS AERUGINOSA IS A GRAM-NEGATIVE, AEROBIC/FACULTATIVELY ANAEROBIC, ROD-SHAPED BACTERIUM THAT IS COMMONLY FOUND IN FRESHWATER ENVIRONMENTS. HOWEVER, P. AERUGINOSA CAN BECOME AN OPPORTUNISTIC PATHOGEN, CAUSING INCREASED MORBIDITY AND MORTALITY IN IMMUNOCOMPROMISED HOSTS, BURN VICTIMS, AND CYSTIC FIBROSIS PATIENTS. FOR EXAMPLE, MORE THAN TWO MILLION PEOPLE ARE INFECTED BY P. AERUGINOSA ANNUALLY, RESULTING IN ALMOST 90,000 DEATHS. NOTABLY, THE ENVIRONMENTAL VERSATILITY OF P. AERUGINOSA, ITS MULTIPLE MECHANISMS FOR PROVIDING ANTIBIOTIC RESISTANCE, AND ITS WIDE RANGE OF DYNAMIC DEFENSES (E.G., BIOFILM FORMATION), RENDER P. AERUGINOSA A MOST CHALLENGING ORGANISM TO EFFECTIVELY TREAT, EVEN IN TODAY'S HOSPITAL SETTINGS. THE GENES RESPONSIBLE FOR P. AERUGINOSA VIRULENCE ARE REGULATED BY A HOST OF SEQUENCE-SPECIFIC TRANSCRIPTION FACTORS. UNFORTUNATELY, OUR KNOWLEDGE REGARDING THEIR TRANSCRIPTIONAL REGULATORY NETWORKS AND HOW THEY CAN BE MODULATED IS WOEFULLY INCOMPLETE. OUR LABORATORY HAS DEVELOPED AN ITERATIVE SELECTION METHOD, RESTRICTION ENDONUCLEASE PROTECTION SELECTION AND AMPLIFICATION (REPSA), THAT HAS PROVEN HIGHLY SUCCESSFUL IN IDENTIFYING CONSENSUS DNA BINDING SEQUENCES AND TARGET GENE PROMOTERS FOR A VARIETY OF TRANSCRIPTION FACTORS IN BACTERIA SUCH AS ESCHERICHIA COLI AND THERMUS THERMOPHILUS. WE NOW PROPOSE TO USE REPSA TO IDENTIFY THE BINDING SITES AND GENES REGULATED BY THE MERR-FAMILY OF TRANSCRIPTION FACTORS IN P. AERUGINOSA, WHICH ARE THOUGHT TO BE INVOLVED IN MEDIATING RESPONSES TO ENVIRONMENTAL STIMULI, E.G., OXIDATIVE STRESS, HEAVY METALS, AND ANTIBIOTICS, INVOLVED IN PATHOGENESIS. ULTIMATELY, SUCH STUDIES WILL ILLUMINATE GLOBAL REGULATORY NETWORKS IN THIS IMPORTANT PATHOGEN, THEREBY FACILITATING THE DEVELOPMENT OF NOVEL ANTI-P. AERUGINOSA THERAPEUTICS. NOTABLY, PER THE GOALS OF THE SURE AWARD MECHANISM, THIS PROJECT WILL SUPPORT THE RESEARCH ACTIVITIES OF THE PI, A FORMER NIH GRANT RECIPIENT, AND WILL ENHANCE THE TRAINING OPPORTUNITIES OF UNDERGRADUATE AND MASTER'S GRADUATE STUDENTS AT A PRIMARILY UNDERGRADUATE/MAJORITY-MINORITY INSTITUTION, A MAJOR FOCUS FOR THE PI. AN AWARD WILL ALLOW THE PI TO CONTINUE A RECORD OF TRAINING STUDENTS WHO HAVE GONE ON TO FURTHER BIOMEDICAL EDUCATION IN GRADUATE OR PROFESSIONAL SCHOOLS AND/OR PURSUING CAREERS IN STEM INDUSTRIES. IT WILL ALSO ALLOW THE PI TO APPLY THE SKILLS HONED THROUGH CONTINUOUS NSF-FUNDED BASIC RESEARCH TO QUESTIONS OF DIRECT RELEVANCE FOR HUMAN HEALTH.

Posted 5/10/24